Quickfind
Show latest about:
Sector
Topic
Keep settings
  Freetext search
 Home
 News
 Analysis
 Features
 Market prices
 Technology guide
 Real estate
 Israel in depth
RSS  feeds
 Enlarge font          Reduce font
Hapoalim: Teva to make acquisition in H1 of 2010
Gilad Sarig: There is little chance that generic Copaxone will hit the market before 2012.
Adi Ben-Israel27 Oct 09 12:45

For the whole article please click here.


Market prices | Site map | Newsletters | Israel links | About us | Support | Report Faults | Advertise | Archive |
Home | News | Analysis | Features | Technology guide | Real estate | Israel in depth | International
GlobesScepia
Application delivery by Application delivery by radware